Table 5.
Results of Subgroup Analysisa
Index |
Original result |
Study Design |
TADs |
Radiography |
|||
Prospective CCT |
RCT |
Miniscrew |
Miniplate |
Lateral Cephalometric |
CBCT |
||
SNA | −0.27 (−0.59, 0.05) | –0.21 (−0.94, 0.51) | –0.28 (−0.56, 0.00) | –0.23 (−0.47, 0.01) | –0.32 (−1.16, 0.53) | –0.05 (–0.54, 0.44) | –0.49 (−0.90, – 0.07) |
SNB | 0.58 (−0.07, 1.23) | 0.83 (−0.84, 2.50) | 0.31 (−0.03, 0.65) | 0.15 (−0.13, 0.42) | 1.13 (−0.30, 2.56) | 0.00 (−0.30, 0.29) | 1.19 (−0.08, 2.47) |
ANB | –0.86 (−1.74, –0.03) | –1.20 (−3.14, 0.74) | –0.51 (−1.07, 0.04) | –0.22 (−0.48, 0.03) | –1.58 (−3.36, 0.21) | –0.24 (−0.56, 0.09) | –1.56 (−3.42, 0.29) |
Co-Po | 1.63 (0.46, 2.80) | 1.36 (0.06, 2.65) | 1.94 (−0.77, 4.65) | 0.25 (−0.92, 1.43) | 2.38 (1.32, 3.43) | 0.69 (−0.17, 1.55) | 2.85 (2.07, 3.64) |
SN-MP | 0.75 (0.28, 1.23) | 0.59 (0.08, 1.09) | 0.92 (−0.01, 1.84) | 0.52 (0.06, 0.99) | 1.06 (0.11, 2.02) | 0.62 (0.08, 1.17) | 0.91 (0.04, 1.78) |
L1-MP | –7.56 (−11.37, −3.76) | –6.43 (−10.04, −2.81) | –10.67 (−13.35, −8.00) | –5.68 (−8.73, −2.63) | –8.23 (−13.46, −3.00) | –8.01 (−12.74, −3.28) | –7.21 (−13.74, −0.68) |
Overjet | 0.47 (−0.98, 1.91) | 1.03 (−1.04, 3.10) | –1.08 (−2.19, 0.03) | –0.75 (−1.62, 0.13) | 1.68 (−1.92, 5.29) | 0.74 (−1.99, 3.47) | –0.08 (−0.33, 0.17) |
Overbite | 0.39 (−0.57, 1.35) | 0.81 (−0.43, 2.04) | –0.90 (−2.05, 0.25) | 0.15 (−1.86, 2.16) | 0.71 (−1.18, 2.60) | 0.66 (−0.88, 2.21) | –0.13 (−0.31, 0.05) |
SN-OP | 1.84 (−5.15, 1.47) | 1.84 (−5.15, 1.47) | – | –0.12 (−2.36, 2.12) | –3.50 (−5.58, −1.42) | 1.84 (−5.15, 1.47) | – |
Naslabial angle | 4.97 (–1.22, 11.17) | – | 4.97 (–1.22, 11.17) | 4.97 (–1.22, 11.17) | – | 4.97 (–1.22, 11.17) | – |
CBCT indicates cone-beam computed tomography; CCT, controlled clinical trial; N/A, not applicable; RCT, randomized controlled trial; TAD, temporary anchorage device.
Bold values indicate significant difference from the original estimates (P<0.05)